<qa>  What is the serum IGF-1IGFBP-3?Patients are assessed at baseline and at 12 months for mammographic breast density, serum hormone levels, and serum IGF-1IGFBP-3. Patients undergo ductal lavage or fine needle aspiration for assessment of supernatant proteomics and breast biomarkers. 